Collegium Pharmaceutical (COLL) EV to FCF (2015 - 2026)

Collegium Pharmaceutical has reported EV to FCF for 12 years, with the latest figure at 14.5 in Q2 2026.

• On a quarterly basis, EV to FCF rose 47.67% year-over-year to 14.5 in Q2 2026; TTM through Jun 2026 was 3.13, a 11.16% decrease from a year earlier, with the FY2025 full-year figure at 3.3, down 9.05% from the prior year.
• EV to FCF was 14.5 for Q2 2026 at Collegium Pharmaceutical, up from 11.43 in the prior quarter.
• The five-year high for EV to FCF was 20.37 in Q1 2023, with the low at 121.76 in Q3 2024.
• Average EV to FCF over 5 years is 1.7, with a median of 9.68 recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: EV to FCF surged 188.69% in 2023, then tumbled 2172.98% in 2024.
• Over 5 years, EV to FCF stood at 9.35 in 2022, then decreased by 2.06% to 9.16 in 2023, then dropped by 4.18% to 8.78 in 2024, then increased by 0.68% to 8.84 in 2025, then jumped by 64.09% to 14.5 in 2026.
• The last three EV to FCF figures came in at 14.5 (Q2 2026), 11.43 (Q1 2026), and 8.84 (Q4 2025), per Business Quant data.